Accrol Group Holdings (ACRL.L) 26.00p £50.76m FFYApr19 trading update Following the conclusion of the restructuring, the Group performed well in Q4 and in line with the management's strategic turnaround objectives, achieving and maintaining acceptable levels of monthly profitability on an Adjusted EBITDA level. Total revenues in FY19 were c.£119m, broadly unchanged on a like for like basis against the prior year, as the Group exited a number of low margin contracts. Sales in the Group's core toilet roll product, however, increased by c.12% year on year to c.£85m from £76m in FY18. Adjusted EBITDA was c.£1m, representing a c.£7m improvement on the prior year despite the substantial impact of FX and material cost headwinds which increased by an estimated c.£10m. Adjusted loss before tax is expected to be in the range of £2.5m to £3.0m. Exceptional costs, primarily associated with the turnaround process, are expected to be in the range of £7.5m to £8.0m. Net debt was reduced faster than anticipated, finishing the year at c.£27.1m, c.£2.5m lower than the previously anticipated level of c.£29.6m, ensuring that the Group comfortably fulfilled on its banking commitments.
Accrol Group Holdings Plc (ACRL.L) Announced, in its FY19 trading update, that following the conclusion of the restructuring, the company performed well in Q4 and in line with the management's strategic turnaround objectives, achieving and maintaining acceptable levels of monthly profitability on an Adjusted EBITDA level. Total revenues in FY19 were £119 million, broadly unchanged on a like for like basis against the prior year, as the company exited a number of low margin contracts. Sales in its core toilet roll product, however, increased by c.12% year on year to c.£85 million from £76 million in FY18. Adjusted EBITDA was c.£1 million, representing a c.£7 million improvement on the prior year despite the substantial impact of FX and material cost headwinds which increased by an estimated c.£10 million. Adjusted loss before tax is expected to be in the range of £2.5 million to £3.0 million. Exceptional costs, primarily associated with the turnaround process, are expected to be in the range of £7.5 million to £8.0 million. Net debt was reduced faster than anticipated, finishing the year at c.£27.1 million, c.£2.5 million lower than the previously anticipated level of c.£29.6 million, ensuring that it comfortably fulfilled on its banking commitments.
RNS Number: 5999 B Accrol Group Holdings PLC 10 June 2019. £119 million, broadly unchanged on a like for like basis against the prior year, as the Group exited a number of low margin contracts. £85 million from £76 million in FY18.
RNS Number: 1523 X Accrol Group Holdings PLC 25 April 2019 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation No. 596/ 2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be...
Accrol Group Holdings Plc (ACRL.L) Announced that John Pilkington has accepted the permanent role of Group Finance Director with immediate effect. Additionally, Hannah Argo, who was appointed Interim Chief Financial Officer whilst a search for a permanent replacement was undertaken, has completed her contract and leaves the company today.
RNS Number: 6771 V Accrol Group Holdings PLC 10 April 2019. Senior Management Change: Appointment of Group Finance Director. Accrol, the UK's leading independent tissue converter, is pleased to announce that John Pilkington has accepted the permanent role of Group Finance Director with immediate effect.
RNS Number: 2392 U Accrol Group Holdings PLC 27 March 2019 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation No. 596/ 2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be...
RNS Number: 1694 U Accrol Group Holdings PLC 27 March 2019. Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. RNS is approved by the Financial Conduct Authority to act as a Primary...
RNS Number: 6834 P Accrol Group Holdings PLC 11 February 2019 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation No. 596/ 2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to...
RNS Number: 2897 P Accrol Group Holdings PLC 06 February 2019 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 8101 N Accrol Group Holdings PLC 22 January 2019 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation No. 596/ 2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to...
RNS Number: 7538 N Accrol Group Holdings PLC 22 January 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7534 N Accrol Group Holdings PLC 22 January 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Accrol Group Holdings Plc (ACRL.L) Announced, in its interim results for the six months ended 31 October 2018, that revenues fell to �57.6 million from �72.3 million posted in the same period preceding year. The company’s loss before tax stood at �8.9 million, compared to a loss of �5.9 million reported in the previous year. The basic loss per share stood at �0.04, compared to a loss of �0.05 reported in the previous year. Separately, the company announced that Steve Townsley has stepped down from the Board and his role as Chief Financial Officer (CFO) for health reasons. Hannah Argo, who joined the Group on 10 January 2019, has been appointed as an Interim CFO.
RNS Number: 7002 N Accrol Group Holdings PLC 22 January 2019 The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation No. 596/ 2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to...
RNS Number: 6819 N Accrol Group Holdings PLC 22 January 2019 22 January 2019. BOARD CHANGE AND SENIOR MANAGEMENT APPOINTMENT. Hannah has extensive experience in senior financial roles gained with a number of global Blue Chip FMCG and Pharma businesses, including Alliance Boots, Robert McBride and latterly Tulip UK.
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK. �A manufacturing, storage and distribution facility in Blackburn;. �A facial tissue plant, also in Blackburn; and.
RNS Number: 7850 M Accrol Group Holdings PLC 10 January 2019 TR-1: S tandard form for notification of major holdings. i Please note that national forms may vary due to specific national legislation as for instance the applicable thresholds or information regarding capital holdings.. Indicate in the relevant section whether the issuer is a non UK issuer..
RNS Number: 5182 M Accrol Group Holdings PLC 08 January 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5171 M Accrol Group Holdings PLC 08 January 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    195.25M

Classification

Market Indices-

Locations

HQ
Delta Building
Roman Road
Blackburn
BB1 2LD
Watchlist